Literature DB >> 24584621

Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Hong Xu1, Makoto Watanabe2, Abdul Rashid Qureshi3, Olof Heimbürger3, Peter Bárány3, Björn Anderstam3, Monica Eriksson3, Peter Stenvinkel3, Bengt Lindholm3.   

Abstract

BACKGROUND AND AIMS: Increased oxidative stress in dialysis patients is thought to contribute to increased mortality; however, confirmatory data are scarce. We analyzed the serum concentration of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative stress, in relation to mortality in hemodialysis (HD) and peritoneal dialysis (PD) patients.
METHODS: Serum 8-OHdG, interleukin 6 (IL-6), other biochemical markers, Davies comorbidity score, and protein-energy wasting (PEW) were assessed in 303 prevalent patients treated with HD (n = 220; age: 63 ± 14 years) or PD (n = 83; age: 64 ± 14 years). Mortality was assessed after a median follow-up of 31 months.
RESULTS: The median (25th - 75th percentile) concentration of 8-OHdG was higher in HD than in PD patients: 1.3 ng/mL (0.9 - 1.8 ng/mL) versus 0.5 ng/mL (0.4 - 0.6 ng/mL), p < 0.001. The HD modality (standard β = 0.57, p < 0.001) and dialysis vintage (standard β = 0.12, p = 0.02) were independent predictors of serum 8-OHdG in a multivariable linear regression model including age, sex, body mass index, dialysis modality (HD or PD), preceding time on dialysis (dialysis vintage), PEW, comorbidity score, IL-6, and use of angiotensin converting-enzyme inhibitors or angiotensin II receptor blockers or statins. During follow-up, 107 patients died. In multivariable Cox regression models including all 303 patients and adjusted for age, sex, body mass index, dialysis modality, dialysis vintage, and comorbidity score, 8-OHdG was significantly associated with all-cause mortality (adjusted hazard ratio: 1.40; 95% confidence limits: 1.05, 1.87 for 1 standard deviation increase of 8-OHdG). In subgroup analyses according to dialysis modality, 8-OHdG was associated with mortality in HD patients but not in PD patients.
CONCLUSIONS: Oxidative stress as assessed by 8-OHdG is an independent predictor of all-cause mortality in dialysis patients. This association was seen in HD patients, but no such association could be demonstrated for PD patients.
Copyright © 2015 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  End-stage renal disease; all-cause mortality; comorbidity; dialysis modality; oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 24584621      PMCID: PMC4406316          DOI: 10.3747/pdi.2013.00259

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  42 in total

1.  Differential effect of statins on diabetic nephropathy in db/db mice.

Authors:  Yukinori Tamura; Toshinori Murayama; Manabu Minami; Masayuki Yokode; Hidenori Arai
Journal:  Int J Mol Med       Date:  2011-08-10       Impact factor: 4.101

2.  Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.

Authors:  Abdulla Al-Hweish; Sherif S Sultan; Khaled Mogazi; Mohamed Y Elsammak
Journal:  Hemodial Int       Date:  2010-06-28       Impact factor: 1.812

3.  Protein oxidative stress and dyslipidemia in dialysis patients.

Authors:  Andresa Marques de Mattos; Larissa Vieira Marino; Paula Payão Ovidio; Alceu Afonso Jordão; Carla Cristina Almeida; Paula Garcia Chiarello
Journal:  Ther Apher Dial       Date:  2011-11-03       Impact factor: 1.762

4.  Oxidative stress is progressively enhanced with advancing stages of CKD.

Authors:  Evangelia Dounousi; Eleni Papavasiliou; Areti Makedou; Kyriakos Ioannou; Konstantinos P Katopodis; Alexandros Tselepis; Kostas C Siamopoulos; Dimitrios Tsakiris
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

5.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Authors:  C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

Review 6.  What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention.

Authors:  Lucia Del Vecchio; Francesco Locatelli; Marina Carini
Journal:  Semin Dial       Date:  2011-02-07       Impact factor: 3.455

Review 7.  Does uremia cause vascular dysfunction?

Authors:  Philippe Brunet; Bertrand Gondouin; Ariane Duval-Sabatier; Laetitia Dou; Claire Cerini; Françoise Dignat-George; Noémie Jourde-Chiche; Angel Argiles; Stéphane Burtey
Journal:  Kidney Blood Press Res       Date:  2011-06-21       Impact factor: 2.687

8.  Associations between the CYBA 242C/T and the MPO -463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients.

Authors:  Debora A Grahl; Jonas Axelsson; Louise Nordfors; Olof Heimburger; Peter Bárány; Yuan-Zhe Gao; Abdul Rashid Qureshi; Sawako Kato; Makoto Watanabe; Mohamed Suliman; Miguel C Riella; Bengt Lindholm; Peter Stenvinkel; Roberto Pecoits-Filho
Journal:  Blood Purif       Date:  2007       Impact factor: 2.614

9.  Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

Authors:  T A Ikizler; J D Morrow; L J Roberts; J A Evanson; B Becker; R M Hakim; Y Shyr; J Himmelfarb
Journal:  Clin Nephrol       Date:  2002-09       Impact factor: 0.975

10.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more
  16 in total

1.  Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX Axis.

Authors:  Tina Oberacker; Peter Fritz; Moritz Schanz; Mark Dominik Alscher; Markus Ketteler; Severin Schricker
Journal:  Antioxidants (Basel)       Date:  2022-06-06

2.  Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients.

Authors:  Naohito Isoyama; Anna Machowska; Abdul Rashid Qureshi; Tae Yamamoto; Björn Anderstam; Olof Heimburger; Peter Barany; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2015-10-22       Impact factor: 1.756

3.  The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease.

Authors:  Filipa Caeiro Alves; Jia Sun; Abdul Rashid Qureshi; Lu Dai; Sunna Snaedal; Peter Bárány; Olof Heimbürger; Bengt Lindholm; Peter Stenvinkel
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

Review 4.  Oxidative Stress in Hemodialysis Patients: A Review of the Literature.

Authors:  Vassilios Liakopoulos; Stefanos Roumeliotis; Xenia Gorny; Evangelia Dounousi; Peter R Mertens
Journal:  Oxid Med Cell Longev       Date:  2017-09-12       Impact factor: 6.543

Review 5.  Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications.

Authors:  Seyed Majid Mousavi Movahhed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-06-07       Impact factor: 3.000

6.  Serum Gamma-Glutamyltransferase Levels Predict Mortality in Patients With Peritoneal Dialysis.

Authors:  Woo-Yeong Park; Su-Hyun Kim; Young Ok Kim; Dong Chan Jin; Ho Chul Song; Euy Jin Choi; Yong Lim Kim; Yon Su Kim; Shin Wook Kang; Nam Ho Kim; Chul Woo Yang; Yong Kyun Kim
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 7.  Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?

Authors:  Anila Duni; Vassilios Liakopoulos; Karolos-Pavlos Rapsomanikis; Evangelia Dounousi
Journal:  Oxid Med Cell Longev       Date:  2017-11-23       Impact factor: 6.543

Review 8.  Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature.

Authors:  Vassilios Liakopoulos; Stefanos Roumeliotis; Xenia Gorny; Theodoros Eleftheriadis; Peter R Mertens
Journal:  Oxid Med Cell Longev       Date:  2017-12-27       Impact factor: 6.543

9.  Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial.

Authors:  Merlin C Thomas; Mark Woodward; Qiang Li; Raelene Pickering; Christos Tikellis; Neil Poulter; Mark E Cooper; Michel Marre; Sophia Zoungas; John Chalmers
Journal:  J Am Heart Assoc       Date:  2018-06-30       Impact factor: 5.501

10.  Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients.

Authors:  Lu Dai; Hideyuki Mukai; Bengt Lindholm; Olof Heimbürger; Peter Barany; Peter Stenvinkel; Abdul Rashid Qureshi
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.